
Join the All of Us Research Program...
The All of Us research program, part of the Precision Medicine Initiative through the National Institutes of Health (NIH), is an...
Investigators will evaluate whether low-dose methotrexate will reduce rates of myocardial infarction, stroke, or cardiovascular death among patients with a recent history of coronary artery disease and either type II diabetes or metabolic syndrome.
Contact Anne McDonald, RN or Kathleen Allain, LPN at 508-368-3929 for more information.
For more information about this study:
https://clinicaltrials.gov/ct2/show/NCT01594333